skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:062401/0019   Pages: 12
Recorded: 01/18/2023
Attorney Dkt #:P6092231PCT/US
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 1
1
Patent #:
NONE
Issue Dt:
Application #:
17999717
Filing Dt:
11/23/2022
Publication #:
Pub Dt:
06/29/2023
Title:
Fibroblast growth factor 21 (FGF21) gene therapy for central nervous system disorders
Assignors
1
Exec Dt:
11/25/2022
2
Exec Dt:
11/27/2022
3
Exec Dt:
11/25/2022
4
Exec Dt:
11/28/2022
5
Exec Dt:
11/25/2022
6
Exec Dt:
11/25/2022
Assignee
1
EDIFICI A - CAMPUS DE LA UAB S/N
CARDANYOLA DEL VALLÈS, SPAIN 08193
Correspondence name and address
N.V. NEDERLANDSCH OCTROOIBUREAU
ANNA VAN BUERENPLEIN 21A
NEW BABYLON CITY OFFICES
THE HAGUE, 2595 DA NETHERLANDS

Search Results as of: 05/04/2024 11:38 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT